Download | < Back |
15 May 2015 | |
Sun Pharma Advanced Research Company Ltd has informed BSE that :<BR><BR>1. Pursuant to the requirements of regulation 8(2) of the Regulations, the Company have formulated and published on its website the "Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information".<BR><BR>2. Pursuant to the requirements of regulation 9(1) of the Regulations, the Company has formulated a Code of Internal Procedures and Code of Conduct for Prevention of Insider Trading. | |
View all announcements for SUN PHARMA ADVANCED RESEARCH COMPANY LTD. | Source: BSE India |